70618-88-1

Basic information

• Product Name: 2-[(4,5-dimethoxyphenyl)methylidene]-N-(4-chlorophenyl)hydrazine-1-carbothioamide
• CAS NO: 70618-88-1
• Molecular Weight: 349.841
• Mol File: 70618-88-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-[(4,5-dimethoxyphenyl)methylidene]-N-(4-chlorophenyl)hydrazine-1-carbothioamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(4,5-dimethoxyphenyl)methylidene]-N-(4-chlorophenyl)hydrazine-1-carbothioamide(70618-88-1)
• EPA Substance Registry System: 2-[(4,5-dimethoxyphenyl)methylidene]-N-(4-chlorophenyl)hydrazine-1-carbothioamide(70618-88-1)

Safety Data

• Hazardous Substances Data: 70618-88-1(Hazardous Substances Data)

Upstream product

• 22814-92-2 4-(p-chlorophenyl)-3-thiosemicarbazide 
• 120-14-9 3,4-dimethoxy-benzaldehyde 

Relevant articles and documents

Influence of complexation of thiosemicarbazone derivatives with Cu (II) ions on their antitumor activity against melanoma cells

A series of thiosemicarbazone derivatives was prepared and their anti-tumor activity in vitro was tested. The X-ray investigation performed for compounds T2, T3 and T5 confirmed the synthesis pathway and assumed molecular structures of analyzed thiosemicarbazones. The conformational preferences of the thiosemicarbazone system were characterized using theoretical calculations by AM1 method. Selected compounds were converted into complexes of Cu (II) ions. The effect of complexing on anti-tumor activity has been investigated. The copper(II) complexes, with Schiff bases T1, T10, T12, T13, and T16 have been synthesized and characterized by chemical and elemental analysis, FTIR spectroscopy and TGA method. Thermal properties of coordination compounds were studied using TG-DTG techniques under dry air atmosphere. G361, A375, and SK-MEL-28 human melanoma cells and BJ human normal fibroblast cells were treated with tested compounds and their cytotoxicity was evaluated with MTT test. The compounds with the most promising anti-tumour activity were then selected and their cytotoxicity was verified with cell cycle analysis and apoptosis/necrosis detection. Additionally, DNA damages in the form of a basic sites presence and the expression of oxidative stress and DNA damage response genes were evaluated. The obtained results indicate that complexation of thiosemicarbazone derivatives with Cu (II) ions improves their antitumor activity against melanoma cells. The observed cytotoxic effect is associated with DNA damage and G2/M phase of cell cycle arrest as well as disorders of the antioxidant enzymes expression.